Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. 2008

Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Universitätsplatz 1, A-8010 Graz, Austria. robert.weis@uni-graz.at

2-Substituted derivatives of the antihistaminic agents Bamipine, Diphenylpyraline and of their 1-phenyl analogues were tested for their antimycobacterial and H(1)-antagonistic activities. They are strong H1-receptor antagonists and also inhibit the growth of mycobacterials with a maximum MIC of 6.25 microg/mL against Mycobacterium tuberculosis H(37)Rv. H1-receptor antagonistic potency was slightly decreased by substitution in ring position 2 and distinctly diminished by N-aryl substitution. The antimycobacterial potency of Diphenylpyraline was in general increased by substitution in ring position 2, whereas only a few Bamipine derivatives showed markedly improved activity. A correlation between the two activities was not detected for those compounds.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010880 Piperidines A family of hexahydropyridines.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
September 1995, Journal of medicinal chemistry,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
April 1989, Chemical & pharmaceutical bulletin,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
January 2001, Arzneimittel-Forschung,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
May 1998, Archiv der Pharmazie,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
January 1998, Pharmaceutica acta Helvetiae,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
February 2005, European journal of medicinal chemistry,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
July 1986, Journal of medicinal chemistry,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
October 1989, Chemical & pharmaceutical bulletin,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
July 2016, Bioorganic & medicinal chemistry letters,
Robert Weis, and Klaus Schweiger, and Johanna Faist, and Erich Rajkovic, and Andreas J Kungl, and Walter M F Fabian, and Walter Schunack, and Werner Seebacher
June 1948, Journal of the American Chemical Society,
Copied contents to your clipboard!